Jazz Pharmaceuticals To Present Advancements In Solid Tumors And Blood Cancer Research At San Antonio Breast Cancer Symposium And American Society Of Hematology Annual Meeting From December 7-10
Jazz Pharmaceuticals To Present Advancements In Solid Tumors And Blood Cancer Research At San Antonio Breast Cancer Symposium And American Society Of Hematology Annual Meeting From December 7-10
爵士製藥將於12月7日至10日在聖安東尼奧乳腺癌研討會和美國血液學年會上展示固性腫瘤和血癌研究的最新進展
Data showcased at SABCS and ASH reflect progress and growth of Jazz's research and development in oncology and demonstrate ongoing efforts to redefine what is possible for cancer treatment
在SABCS和ASH上展示的數據反映了爵士製藥在腫瘤學領域研究與開發的進展和成長，並展示了重新定義癌症治療可能性的持續努力。
DUBLIN, Dec. 3, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the Company and its partners will present two abstracts at the 2024 San Antonio Breast Cancer Symposium (SABCS) from December 10-13 and 13 abstracts at the 66th Annual American Society of Hematology (ASH) Annual Meeting from December 7-10.
2024年12月3日都柏林/美通社 - 爵士製藥plc（納斯達克：JAZZ）今天宣佈，公司及其合作伙伴將在2024年12月10日至13日的聖安東尼奧乳腺癌研討會上發佈兩份摘要，並將在12月7日至10日的第66屆美國血液學會（ASH）年會上發表13個摘要。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間